173 related articles for article (PubMed ID: 735720)
21. Differential effects on suicidal ideation of mianserin, maprotiline and amitriptyline.
Montgomery S; Cronholm B; Asberg M; Montgomery DB
Br J Clin Pharmacol; 1978; 5 Suppl 1(Suppl 1):77S-80S. PubMed ID: 341948
[No Abstract] [Full Text] [Related]
22. Viloxazine: assessment of potential rapid antidepressant action.
Edwards JG
Br Med J; 1977 Nov; 2(6098):1327. PubMed ID: 338106
[No Abstract] [Full Text] [Related]
23. [Double blind study on maprotiline, an example of a multidimensional psychopharmacologic experiment (author's transl)].
Bergener M; Hesse C; Hummel F; Husser J; Kern U; Neller K; Reiners I
Pharmakopsychiatr Neuropsychopharmakol; 1978 Mar; 11(2):63-7. PubMed ID: 347465
[TBL] [Abstract][Full Text] [Related]
24. [Clinical experimentation with viloxazine in depressive states].
Fontan M; Goudemand M; Pellerin-Millecamps E
Lille Med; 1979 Dec; 24(10):821-4. PubMed ID: 529970
[No Abstract] [Full Text] [Related]
25. Clinical experience with maprotiline.
Kabes J; Dostal T; Roth Z
Act Nerv Super (Praha); 1982 May; 24(2):93-8. PubMed ID: 7048837
[No Abstract] [Full Text] [Related]
26. Viloxazine in depressed women: clinical response and cardiovascular effects.
Corona GL; Frattini P; Cucchi ML; Santagostino G; Schinelli S; Zerbi F; Cairoli S; Tosca P; Savoldi F
Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):322-7. PubMed ID: 3623737
[TBL] [Abstract][Full Text] [Related]
27. [Clinico-experimental data on the efficacy of viloxazine in depressive states].
Pirozynski T; Chiriţă V; Mungiu OC; Luchian M; Cosmovici N
Rev Med Chir Soc Med Nat Iasi; 1988; 92(1):49-52. PubMed ID: 3393762
[No Abstract] [Full Text] [Related]
28. [The effect of maprotiline on target symptoms of depressive states].
Faltus F
Act Nerv Super (Praha); 1982 May; 24(2):99-100. PubMed ID: 7102230
[No Abstract] [Full Text] [Related]
29. The therapeutic effect of viloxazine (Vivalan ICI) in hospitalized depressive patients -- a multicenter study.
Kabes J; Náhunek K; Molcan J; Hynek K; Dostal T; Svestka J; Faltus F; Caplová T
Act Nerv Super (Praha); 1978 Dec; 20(4):251-2. PubMed ID: 735719
[No Abstract] [Full Text] [Related]
30. [Viloxazine. Aspects of the therapeutic effect of the antidepressive agent viloxazine (Vivalan ICI) in the opinion of practicing neurologists].
Jungkunz G
MMW Munch Med Wochenschr; 1982 Aug; 124(32-33):712-4. PubMed ID: 6813688
[No Abstract] [Full Text] [Related]
31. [Therapeutic use of viloxazine (Vivalan ICI) in depressed hospital out-patients (author's transl)].
Kabes J; Dostal T
Cesk Psychiatr; 1976 Dec; 72(6):384-9. PubMed ID: 1000703
[No Abstract] [Full Text] [Related]
32. Viloxazine (Vivalan ICI) in depression: results of a field trial of 276 patients in neuropsychiatric practice.
Sebjanic V; Grombein S
Adv Biochem Psychopharmacol; 1982; 32():113-20. PubMed ID: 7046360
[TBL] [Abstract][Full Text] [Related]
33. [Results of the clinical trial with viloxazine (Vivalan ICI). A part of the multicentre study (author's transl)].
Kabes J; Dostal T
Cesk Psychiatr; 1979 Aug; 75(4):225-31. PubMed ID: 393416
[No Abstract] [Full Text] [Related]
34. Therapeutic superiority of maprotiline versus doxepin in geriatric depression.
Gwirtsman HE; Ahles S; Halaris A; DeMet E; Hill MA
J Clin Psychiatry; 1983 Dec; 44(12):449-53. PubMed ID: 6361005
[TBL] [Abstract][Full Text] [Related]
35. A comparative study of viloxazine and imipramine in the treatment of depressive states.
Elwan O
J Int Med Res; 1980; 8(1):7-17. PubMed ID: 7358207
[No Abstract] [Full Text] [Related]
36. [Evaluation of the antidepressive action of maprotiline].
Bilikiewicz A; Landowski J
Psychiatr Pol; 1976; 10(4):367-74. PubMed ID: 981412
[No Abstract] [Full Text] [Related]
37. A comparison of maprotiline (Ludiomil) and slow release amitriptyline (Tryptizol SR).
McMillin WP
J Int Med Res; 1977; 5 Suppl 4():51-8. PubMed ID: 590611
[No Abstract] [Full Text] [Related]
38. Fluoxetine 40 mg vs maprotiline 75 mg in the treatment of out-patients with depressive disorders.
Poelinger W; Haber H
Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():47-50. PubMed ID: 2644340
[No Abstract] [Full Text] [Related]
39. A clinical and pharmacological study of the antidepressant activity of viloxazine in adult and elderly patients.
Tosca P; Zerbi F; Romani A; Molini G; Cairoli S; Montagna M; Gabba A; Groppi A
Int J Clin Pharmacol Ther Toxicol; 1985 May; 23(5):270-3. PubMed ID: 4008117
[TBL] [Abstract][Full Text] [Related]
40. Treatment of depression in outpatients: a controlled comparison of the onset of action of amoxapine and maprotiline.
Fabre LF
J Clin Psychiatry; 1985 Dec; 46(12):521-4. PubMed ID: 3905772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
